Nakashima Hideyuki 中島英行

… Alternative Names

Researcher Number	30437032
Other IDs
Affiliation (Current)	2022: 横浜市立大学, 医学研究科, 客員研究員
Affiliation (based on the past Project Information) *help	2016 – 2020: 横浜市立大学, 医学研究科, 客員研究員 2012 – 2015: 横浜市立大学, 附属病院, 助教
Review Section/Research Field	Principal Investigator Pathobiological dentistry/Dental radiology Except Principal Investigator Pathobiological dentistry/Dental radiology / Basic Section 57020:Oral pathobiological science-related
Keywords	Principal Investigator 温熱療法 / 分子標的薬 / 口腔癌 / 併用療法 / 口腔扁平上皮癌 / 磁性体 / 抗EGFR抗体 Except Principal Investigator 温熱療法 / IL-1阻害薬 / 進行口腔癌 … More

温熱療法とIL-1R阻害薬の臨床応用に向けた併用療法の開発
- Principal Investigator
  
  小栗千里
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 57020:Oral pathobiological science-related
- Research Institution
  Yokohama City University
Development of hyperthermia for the treatment of oral cancer using magnetite anti-EGFR antibody.Principal Investigator
- Principal Investigator
  
  NAKASHIMA Hideyuki
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pathobiological dentistry/Dental radiology
- Research Institution
  Yokohama City University
Development of combination theray with hyperthermia and Interleukin-1 inhibitor.
- Principal Investigator
  
  SENRI Oguri
- Project Period (FY)
  2014 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pathobiological dentistry/Dental radiology
- Research Institution
  Yokohama City University
Development of combination theray with hyperthermia and targeted therapy for clinical application.Principal Investigator
- Principal Investigator
  
  NAKASHIMA Hideyuki
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Pathobiological dentistry/Dental radiology
- Research Institution
  Yokohama City University
Development of combination therapy with hyperthermia and targeted therapyPrincipal Investigator
- Principal Investigator
  
  NAKASHIMA Hideyuki
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Pathobiological dentistry/Dental radiology
- Research Institution
  Yokohama City University

All 2017 2016 2015 2014 2013 2012 Other

All Journal Article Presentation

[Journal Article] Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.2013
- Author(s)
  Hall B, Nakashima H, Sun ZJ, Sato Y, Bian Y, Husain SR, Puri RK, Kulkarni AB.
- Journal Title
  
  J Transl Med.
  
  Volume: 11 Pages: 45-45
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24792006
[Journal Article] Review: IL-13 receptor-directed cancer vaccines and immunotherapy.2012
- Author(s)
  Nakashima H, Husain SR, Puri RK.
- Journal Title
  
  Immunotherapy
  
  Volume: 4 Pages: 443-451
- DOI
  10.2217/imt.12.28
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.2017
- Author(s)
  Nakashima H, Kioi M, Yanagida K, Okubo M, Sugiura K, Mitsudo K, Tohnai I
- Organizer
  6th World Oral Cancer Congress of the International Academy of Oral Oncology (IAOO), Bangalore, India
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11678
[Presentation] 局所進行下顎歯肉癌T4症例の検討.2016
- Author(s)
  小栗千里, 光藤健司, 小泉敏之, 大橋伸英, 柴崎麻衣子, 飯田昌樹, 岩井俊憲, 中島英行, 廣田　誠, 來生　知，藤内　祝
- Organizer
  第40回日本頭頸部癌学会
- Place of Presentation
  ソニックシティー（埼玉県大宮市）
- Year and Date
  2016-06-09
- Data Source
  KAKENHI-PROJECT-26462847
[Presentation] ヒト口腔扁平上皮癌細胞に対するmild-hyperthermiaとcetuximab併用効果の検討．2016
- Author(s)
  飯坂友宏，中島英行，來生　知，大久保牧子，杉浦　圭，小栗千里，小泉敏之，光藤健司，藤内　祝
- Organizer
  日本ハイパーサーミア学会第34回大会
- Place of Presentation
  つくば国際会議場(茨城県つくば市）
- Year and Date
  2016-09-02
- Data Source
  KAKENHI-PROJECT-26462847
[Presentation] Hyperthermia enhances the therapeutic efficacy of IL-13 cytotoxin in human oral squamous cell carcinoma.2016
- Author(s)
  11.Nakashima H, Okubo M, Kioi M, Miyajima A, Iisaka T, Sugiura K, Itaru S, Koizumi T, Mitsudo K and Tohnai I.
- Organizer
  The 12th International congress of hyperthermic oncology
- Place of Presentation
  New Orleans, USA
- Year and Date
  2016-04-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26861575
[Presentation] ヒト口腔扁平上皮癌細胞に対するmild-hyperthermiaとcetuximab併用効果の検討2016
- Author(s)
  13.飯坂友宏，中島英行，來生　知，大久保牧子，杉浦　圭，小栗千里，小泉敏之，光藤健司，藤内　祝
- Organizer
  日本ハイパーサーミア学会第34回大会
- Place of Presentation
  つくば国際会議場(茨木県つくば市）
- Year and Date
  2016-09-02
- Data Source
  KAKENHI-PROJECT-26861575
[Presentation] Hyperthermia enhances the therapeutic efficacy of IL-13 cytotoxin in human oral squamous cell carcinoma.2016
- Author(s)
  H. Nakashima, M. Okubo, M. Kioi, A. Miyajima, T. Iisaka, K. Sugiura, I. Sato, T. Koizumi, K. Mitsudo and I. Tohnai
- Organizer
  12th International Congress of Hyperthermic Oncology
- Place of Presentation
  intercontinental hotel (ニューオーリンズ、アメリカ)
- Year and Date
  2016-04-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26861575
[Presentation] Combination therapy with Hyperthermia enhances the therapeutic efficacy of IL-13 cytotoxin in human oral squamous cell carcinoma.2016
- Author(s)
  H. Nakashima, T. Iisaka, M. Kioi, A. Miyajima, M. Okubo, K. Sugiura, S. Itaru, S. Murata, K. Mitsudo and I. Tohnai
- Organizer
  The 12th International congress of hyperthermic oncology
- Place of Presentation
  InterContinental Hotel （ニューオリンズ、アメリカ）
- Year and Date
  2016-04-11
- Data Source
  KAKENHI-PROJECT-26462847
[Presentation] Combination therapy with hyperthermia and cetuximab in oral squamous cell carcinoma.2015
- Author(s)
  H. Nakashima, T. Iisaka, M. Kioi, A. Miyajima, M. Okubo, K. Sugiura, S. Itaru, S. Murata, K. Mitsudo and I. Tohnai
- Organizer
  International Academy of Oral Oncology (IAOO）
- Place of Presentation
  シェラトン・サンパウロWTCホテル（サンパウロ、ブラジル）
- Year and Date
  2015-07-08
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26861575
[Presentation] 口腔癌におけるIL-13Rα2の発現と新たな分子標的薬の可能性について2015
- Author(s)
  中島英行・來生　知・宮島彰嘉・飯坂友宏・杉浦　圭・大久保牧子・佐藤　格・廣田　誠・光藤健司・藤内　祝
- Organizer
  第60回日本口腔外科学会総会・学術大会，公募ワークショップ（口演）口腔がんリサーチの最前線
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-26861575
[Presentation] 口腔癌における温熱療法と分子標的薬の併用療法の開発2015
- Author(s)
  中島英行，大久保牧子，飯坂友宏，杉浦　圭，飯田昌樹，佐藤　格，小泉敏之，來生　知，光藤健司，藤内　祝
- Organizer
  日本ハイパーサーミア学会　第32回大会（シンポジウム）
- Place of Presentation
  KKRホテル大阪（大阪府大阪市）
- Year and Date
  2015-09-04
- Data Source
  KAKENHI-PROJECT-26861575
[Presentation] 口腔扁平上皮癌における温熱療法と分子標的薬の併用療法の開発2015
- Author(s)
  中島英行，大久保牧子，來生　知，杉浦　圭，佐藤　格，飯田　昌樹，小泉敏之
- Organizer
  第19回関東ハイパーサーミア研究会
- Place of Presentation
  国立がん研究センター中央病院　国際研究交流会館（東京都中央区）
- Year and Date
  2015-01-17
- Data Source
  KAKENHI-PROJECT-26861575
[Presentation] 口腔癌における温熱療法と分子標的薬の併用療法の開発2015
- Author(s)
  中島英行、大久保牧子、宮島章嘉、飯坂友宏、杉浦　圭、飯田昌樹、佐藤　格、小泉俊之、來生　知、光藤健司，藤内　祝
- Organizer
  日本ハイパーサーミア学会第32回大会　シンポジウム
- Place of Presentation
  KKRホテル大阪（大阪府大阪市）
- Year and Date
  2015-09-04
- Data Source
  KAKENHI-PROJECT-26462847
[Presentation] A Combination therapy with hyperthermia and immunotoxin targeted IL-13 receptor alpha2 for human oral cancer cells2014
- Author(s)
  M. Okubo, H. Nakashima, M. Kioi, T. Sakaguchi, H. Umemura, K. Sugiura, I. Sato, M. Iida, K. Mitsudo　and I. Tohnai
- Organizer
  第6回アジアハイパーサーミア腫瘍学会・第31回日本ハイパーサーミア学会合同大会
- Place of Presentation
  AOSSA　（福井県）
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] 口腔扁平上皮癌における分子標的薬と温熱療法との併用療法の開発2013
- Author(s)
  中島　英行，來生　知，大久保牧子，杉浦　圭，佐藤　格，飯田　昌樹，佐藤　有紀，光藤　健司，藤内　祝
- Organizer
  第30回　日本ハイパーサーミア学会・学術大会
- Place of Presentation
  横浜シンポジア（神奈川県）
- Invited
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] 口腔扁平上皮癌における分子標的薬と温熱療法との併用療法の開発. シンポジウム2013
- Author(s)
  中島英行, 來生知, 大久保牧子, 杉浦圭, 佐藤格, 飯田昌樹, 佐藤有紀, 光藤健司, 藤内祝
- Organizer
  第30回日本ハイパーサーミア学会・学術大会
- Place of Presentation
  横浜
- Year and Date
  2013-08-31
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] Hyperthermia sensitizes resistant human oral cancer cells to IL-13 cytotoxin2012
- Author(s)
  H. Nakashima, M. Kioi, M. Okubo, K. Sugiura, I. Sato, M. Iida, K. Mitsudo, S. R. Husain, R. K. Puri and I. Tohnai
- Organizer
  ICHO & JCTM 2012 meeting
- Place of Presentation
  ハイアットリージェンシー（京都府）
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] Hyperthermia sensitizes resistant human oral cancer cells to IL-13 cytotoxin2012
- Author(s)
  Nakashima H, Kioi M, Okubo M, Sugiura K, Sato I, Iida M, Mitsudo K, Husain SR, Puri RK, Tohnai I
- Organizer
  ICHO & JCTM 2012 meeting
- Place of Presentation
  Kyoto, Japan
- Year and Date
  2012-08-29
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] Interleukin-13 Receptor α2 chain Regulation in Human Head and Neck by Hyperthermia in vitro2012
- Author(s)
  Sugiura K, Nakashima H, Okubo M, Sato I, Iida M, Sato Y, Kioi M, Mitsudo K, Husain SR, Tohnai, Puri RK
- Organizer
  International Conference on Diabetes Mellitus and Cancer (Dia-Can' 12)
- Place of Presentation
  Tamil Nadu, India
- Year and Date
  2012-12-15
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] Interleukin-13 Receptor α2 chain Regulation in Human Head and Neck by Hyperthermia in vitro2012
- Author(s)
  Kei Sugiura, Hideyuki Nakashima, Makiko Okubo, Itaru Sato, Masaki. Iida, Yuki Sato, Mitomu Kioi, Kenji Mitsudo, Syed R. Husain, Iwai Tohnai and Raj K. Puri
- Organizer
  International Conference on Diabetes Mellitus and Cancer (Dia-Can’ 12)
- Place of Presentation
  Tamil Nadu, India
- Invited
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] A Novel Combination Immunotherapy for Targeting Murine Breast Cancer with IL-13 Receptor alpha 2 DNA Vaccine and an Immunotoxin2012
- Author(s)
  Nakashima H, Husain SR, Sato Y. Kioi M. Tohnai I, Puri RK
- Organizer
  International Conference on Diabetes Mellitus and Cancer (Dia-Can' 12)
- Place of Presentation
  Tamil Nadu, India
- Year and Date
  2012-12-15
- Data Source
  KAKENHI-PROJECT-24792006
[Presentation] A Combination therapy with hyperthermia and IL-13 cytotoxin for human oral cancer cells.
- Author(s)
  13.Okubo M, Nakashima H, Kioi M, Sakaguchi T, Uemura, Sugiura K, Sato I, Iida M, Mitsudo K, Tohnai I
- Organizer
  6th Asian Congress of Hyperthermia Oncology
- Place of Presentation
  AOSSA（福井県福井市）
- Year and Date
  2014-09-05 – 2014-09-06
- Data Source
  KAKENHI-PROJECT-26861575

1. 來生知 (30545059)

# of Collaborated Projects: 3 results

# of Collaborated Products: 5 results
2. 光藤健司 (70303641)

# of Collaborated Projects: 3 results

# of Collaborated Products: 5 results
3. SENRI Oguri (30400394)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
4. 岡本喜之 (80536227)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Nakashima Hideyuki 中島 英行

NAKASHIMA Hideyuki 中島 英行

Research Projects

Research Products

Co-Researchers

温熱療法とIL-1R阻害薬の臨床応用に向けた併用療法の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of hyperthermia for the treatment of oral cancer using magnetite anti-EGFR antibody.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of combination theray with hyperthermia and Interleukin-1 inhibitor.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of combination theray with hyperthermia and targeted therapy for clinical application.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of combination therapy with hyperthermia and targeted therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.2013

Author(s)

Journal Title

Data Source

[Journal Article] Review: IL-13 receptor-directed cancer vaccines and immunotherapy.2012

Author(s)

Journal Title

DOI

Data Source

[Presentation] Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.2017

Author(s)

Organizer

Data Source

[Presentation] 局所進行下顎歯肉癌T4症例の検討.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] ヒト口腔扁平上皮癌細胞に対するmild-hyperthermiaとcetuximab併用効果の検討．2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Hyperthermia enhances the therapeutic efficacy of IL-13 cytotoxin in human oral squamous cell carcinoma.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] ヒト口腔扁平上皮癌細胞に対するmild-hyperthermiaとcetuximab併用効果の検討2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Hyperthermia enhances the therapeutic efficacy of IL-13 cytotoxin in human oral squamous cell carcinoma.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Combination therapy with Hyperthermia enhances the therapeutic efficacy of IL-13 cytotoxin in human oral squamous cell carcinoma.2016

Author(s)

Nakashima Hideyuki 中島英行

NAKASHIMA Hideyuki 中島英行